Interspecies molecular chimeras of kit help define the binding site of the stem cell factor

The extracellular portion of the kit-encoded receptor for the stem cell factor (SCF) comprises five immunoglobulin (Ig)-like domains. To localize the ligand recognition site, we exploited the lack of binding of human SCF to the murine receptor by using human-mouse hybrids of Kit and species-specific monoclonal antibodies (MAbs) that inhibit ligand binding. Replacement of the three N-terminal Ig-like domains of the murine Kit with the corresponding portion of the human receptor conferred upon the chimeric receptor high-affinity binding of the human ligand as well as of human-specific ligand-inhibitory MAbs. By constructing five chimeric murine Kit proteins which individually contain each of these three human Ig-like units or pairs of them, we found that the second human domain confers upon the mouse Kit high-affinity binding of the human ligand and also binding of species-specific SCF-competitive MAbs. Nevertheless, the flanking Ig-like domains also affect high-affinity recognition of SCF. Moreover, it appears that the determinants that define ligand specificity of the murine and the human receptors do not structurally coincide. This observation allowed us to identify a chimeric receptor that displayed a dual specificity; namely, it bound with high affinity either the human or the murine SCF molecules and reacted with mouse- as well as human-specific ligand-inhibitory MAbs. Conversely, another chimera, which included all of the five Ig-like domains, bound neither ligand. In conclusion, interdomain packing involving the second Ig-like domain of human Kit and noncontiguous structural motifs of the receptor are involved in SCF recognition.

[1]  S. Lev,et al.  Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. , 1992, The Journal of biological chemistry.

[2]  S. Lev,et al.  A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. , 1992, Journal of Biological Chemistry.

[3]  Y. Yarden,et al.  A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. , 1992, The EMBO journal.

[4]  S. Aaronson,et al.  A deletion in the extracellular domain of the alpha platelet-derived growth factor (PDGF) receptor differentially impairs PDGF-AA and PDGF-BB binding affinities. , 1992, The Journal of biological chemistry.

[5]  S. Lev,et al.  Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Werner,et al.  Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities , 1992, Molecular and cellular biology.

[7]  P. Besmer.  The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. , 1991, Current opinion in cell biology.

[8]  A. Ullrich,et al.  Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. , 1991, The Journal of biological chemistry.

[9]  S. Nishikawa,et al.  In utero manipulation of coat color formation by a monoclonal anti‐c‐kit antibody: two distinct waves of c‐kit‐dependency during melanocyte development. , 1991, The EMBO journal.

[10]  N. Møłler,et al.  The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Ullrich,et al.  Noncontiguous regions in the extracellular domain of EGF receptor define ligand-binding specificity. , 1991, Cell regulation.

[12]  W. Rutter,et al.  The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. , 1990, The Journal of biological chemistry.

[13]  N. Copeland,et al.  Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles , 1990, Cell.

[14]  C. March,et al.  Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms , 1990, Cell.

[15]  P. Leder,et al.  The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus , 1990, Cell.

[16]  P. Leder,et al.  The kit ligand: A cell surface molecule altered in steel mutant fibroblasts , 1990, Cell.

[17]  K. Zsebo,et al.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium , 1990, Cell.

[18]  David A. Williams,et al.  Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor , 1990, Cell.

[19]  K. Zsebo,et al.  Primary structure and functional expression of rat and human stem cell factor DNAs , 1990, Cell.

[20]  C. March,et al.  Identification of a ligand for the c-kit proto-oncogene , 1990, Cell.

[21]  A. Ullrich,et al.  Functional analysis of the ligand binding site of EGF‐receptor utilizing chimeric chicken/human receptor molecules. , 1989, The EMBO journal.

[22]  D. Housman,et al.  The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene , 1988, Cell.

[23]  V. Chapman,et al.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus , 1988, Nature.

[24]  C. Heldin,et al.  Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. , 1988, The EMBO journal.

[25]  F. Ruddle,et al.  Primary structure of c‐kit: relationship with the CSF‐1/PDGF receptor kinase family–oncogenic activation of v‐kit involves deletion of extracellular domain and C terminus. , 1988, The EMBO journal.

[26]  A. Ullrich,et al.  Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. , 1987, The EMBO journal.

[27]  John E. Murphy,et al.  A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family , 1986, Nature.

[28]  Tom Maniatis,et al.  Transformation of mammalian cells with genes from procaryotes and eucaryotes , 1979, Cell.

[29]  D. Bennett.  Developmental analysis of a mutation with pleiotropic effects in the mouse , 1956 .

[30]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[31]  T. Fleming,et al.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Hood,et al.  Diversity of the immunoglobulin gene superfamily. , 1989, Advances in immunology.

[33]  A. F. Williams,et al.  The immunoglobulin superfamily--domains for cell surface recognition. , 1988, Annual review of immunology.

[34]  E. Russell.  Hereditary anemias of the mouse: a review for geneticists. , 1979, Advances in genetics.

[35]  Y. Yarden,et al.  Oncogenic forms of the neu / HER 2 tyrosine kinase are permanently coupled to phospholipase Cy , 2022 .